Press Release – Adults with XLH will now be able to access new treatment options on the NHS in Scotland

Commenting on SMC’s decision, XLH UK founder Oliver Gardiner explained that “This is fantastic news for adults with XLH in Scotland and is a leap forward, setting a precedent as the first of the UK nations to recommend burosumab for the eligible adult population. This life-changing treatment is the first to tackle the underlying problem, with the potential to lessen the significant physical and emotional challenges that adults with XLH are faced with on a daily basis.”

Please read our press release below.

You can view it here: